| UniProt ID | LIN54_HUMAN | |
|---|---|---|
| UniProt AC | Q6MZP7 | |
| Protein Name | Protein lin-54 homolog | |
| Gene Name | LIN54 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 749 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Component of the DREAM complex, a multiprotein complex that can both act as a transcription activator or repressor depending on the context. [PubMed: 17671431] | |
| Protein Sequence | MEVVPAEVNSLLPEEIMDTGITLVDDDSIEAVIVSSPIPMETELEEIVNINSTGDSTATPISTEPITVYSNHTNQVAVNTTITKADSNTTVKPAFPSGLQKLGAQTPVTISANQIILNKVSQTSDLKLGNQTLKPDGQKLILTTLGKSGSPIVLALPHSQLPQAQKVTTQAQSGDAKLPPQQIKVVTIGGRPEVKPVIGVSALTPGSQLINTTTQPSVLQTQQLKTVQIAKKPRTPTSGPVITKLIFAKPINSKAVTGQTTQVSPPVIAGRVLSQSTPGTPSKTITISESGVIGSTLNSTTQTPNKIAISPLKSPNKAVKSTVQTITVGGVSTSQFKTIIPLATAPNVQQIQVPGSKFHYVRLVTATSASSSTQPVSQNPSTNTQPLQQAKPVVVNTTPVRMSVPIVSAQAVKQVVPKPINPTSQIVTTSQPQQRLIMPATPLPQIQPNLTNLPPGTVLAPAPGTGNVGYAVLPAQYVTQLQQSSYVSIASNSTFTGTSGIQTQARLPFNGIIPSESASRPRKPCNCTKSLCLKLYCDCFANGEFCNNCNCTNCYNNLEHENERQKAIKACLDRNPEAFKPKIGKGKEGESDRRHSKGCNCKRSGCLKNYCECYEAKIMCSSICKCIGCKNFEESPERKTLMHLADAAEVRVQQQTAAKTKLSSQISDLLTRPTPALNSGGGKLPFTFVTKEVAEATCNCLLAQAEQADKKGKSKAAAERMILEEFGRCLMSVINSAGKAKSDPCAMNC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 (in isoform 3) | Ubiquitination | - | 8.57 | - | |
| 14 (in isoform 3) | Phosphorylation | - | 61.19 | 25159151 | |
| 16 (in isoform 3) | Phosphorylation | - | 2.63 | 25627689 | |
| 23 | Acetylation | IMDTGITLVDDDSIE HHHCCCEEECCCCCE | 3.62 | 19608861 | |
| 28 | Acetylation | ITLVDDDSIEAVIVS CEEECCCCCEEEEEC | 29.35 | 19608861 | |
| 35 | Phosphorylation | SIEAVIVSSPIPMET CCEEEEECCCCCCCC | 21.19 | 26074081 | |
| 36 | Phosphorylation | IEAVIVSSPIPMETE CEEEEECCCCCCCCC | 18.89 | 26074081 | |
| 42 | Phosphorylation | SSPIPMETELEEIVN CCCCCCCCCHHHHHC | 39.35 | 26074081 | |
| 92 | Acetylation | ADSNTTVKPAFPSGL CCCCCCCCCCCCCHH | 28.65 | 23954790 | |
| 92 | Ubiquitination | ADSNTTVKPAFPSGL CCCCCCCCCCCCCHH | 28.65 | - | |
| 101 | Ubiquitination | AFPSGLQKLGAQTPV CCCCHHHHCCCCCCE | 54.66 | - | |
| 106 | Phosphorylation | LQKLGAQTPVTISAN HHHCCCCCCEEEECC | 21.13 | 25159151 | |
| 106 | O-linked_Glycosylation | LQKLGAQTPVTISAN HHHCCCCCCEEEECC | 21.13 | 20068230 | |
| 109 | O-linked_Glycosylation | LGAQTPVTISANQII CCCCCCEEEECCHHH | 15.49 | 20068230 | |
| 109 | Phosphorylation | LGAQTPVTISANQII CCCCCCEEEECCHHH | 15.49 | 27174698 | |
| 111 | O-linked_Glycosylation | AQTPVTISANQIILN CCCCEEEECCHHHHH | 16.29 | 20068230 | |
| 111 | Phosphorylation | AQTPVTISANQIILN CCCCEEEECCHHHHH | 16.29 | 27174698 | |
| 119 | Ubiquitination | ANQIILNKVSQTSDL CCHHHHHCCCCCCCC | 39.56 | - | |
| 121 | Phosphorylation | QIILNKVSQTSDLKL HHHHHCCCCCCCCCC | 29.38 | 27174698 | |
| 123 | Phosphorylation | ILNKVSQTSDLKLGN HHHCCCCCCCCCCCC | 19.39 | 27174698 | |
| 124 | Phosphorylation | LNKVSQTSDLKLGNQ HHCCCCCCCCCCCCE | 33.05 | 27174698 | |
| 127 | Ubiquitination | VSQTSDLKLGNQTLK CCCCCCCCCCCEEEC | 60.38 | - | |
| 134 | Ubiquitination | KLGNQTLKPDGQKLI CCCCEEECCCCCEEE | 44.44 | - | |
| 134 | Acetylation | KLGNQTLKPDGQKLI CCCCEEECCCCCEEE | 44.44 | 26051181 | |
| 136 | Acetylation | GNQTLKPDGQKLILT CCEEECCCCCEEEEE | 71.25 | 19608861 | |
| 136 | Ubiquitination | GNQTLKPDGQKLILT CCEEECCCCCEEEEE | 71.25 | 19608861 | |
| 139 | Ubiquitination | TLKPDGQKLILTTLG EECCCCCEEEEEECC | 42.92 | - | |
| 139 | Sumoylation | TLKPDGQKLILTTLG EECCCCCEEEEEECC | 42.92 | 28112733 | |
| 143 | Phosphorylation | DGQKLILTTLGKSGS CCCEEEEEECCCCCC | 17.00 | 25954137 | |
| 144 | Phosphorylation | GQKLILTTLGKSGSP CCEEEEEECCCCCCC | 30.02 | 25954137 | |
| 147 | Ubiquitination | LILTTLGKSGSPIVL EEEEECCCCCCCEEE | 55.55 | - | |
| 147 | Acetylation | LILTTLGKSGSPIVL EEEEECCCCCCCEEE | 55.55 | 25953088 | |
| 148 | Phosphorylation | ILTTLGKSGSPIVLA EEEECCCCCCCEEEE | 42.58 | 24732914 | |
| 150 | Phosphorylation | TTLGKSGSPIVLALP EECCCCCCCEEEEEC | 20.67 | 25159151 | |
| 159 | Phosphorylation | IVLALPHSQLPQAQK EEEEECHHHCCCCCC | 31.32 | 25954137 | |
| 166 | Ubiquitination | SQLPQAQKVTTQAQS HHCCCCCCCCCCCCC | 44.56 | - | |
| 168 | O-linked_Glycosylation | LPQAQKVTTQAQSGD CCCCCCCCCCCCCCC | 21.89 | 20068230 | |
| 195 | Ubiquitination | IGGRPEVKPVIGVSA ECCCCCCCCEEEEEE | 31.72 | - | |
| 195 | Acetylation | IGGRPEVKPVIGVSA ECCCCCCCCEEEEEE | 31.72 | 26051181 | |
| 235 | Phosphorylation | QIAKKPRTPTSGPVI EECCCCCCCCCCCCE | 39.17 | 26657352 | |
| 235 | O-linked_Glycosylation | QIAKKPRTPTSGPVI EECCCCCCCCCCCCE | 39.17 | 20068230 | |
| 237 | Phosphorylation | AKKPRTPTSGPVITK CCCCCCCCCCCCEEE | 45.78 | 28450419 | |
| 237 | O-linked_Glycosylation | AKKPRTPTSGPVITK CCCCCCCCCCCCEEE | 45.78 | 20068230 | |
| 238 | O-linked_Glycosylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 32574038 | |
| 238 | Phosphorylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 28450419 | |
| 238 | O-linked_Glycosylation | KKPRTPTSGPVITKL CCCCCCCCCCCEEEE | 42.16 | 20068230 | |
| 243 | Phosphorylation | PTSGPVITKLIFAKP CCCCCCEEEEEEEEE | 21.74 | 28450419 | |
| 243 | O-linked_Glycosylation | PTSGPVITKLIFAKP CCCCCCEEEEEEEEE | 21.74 | 20068230 | |
| 244 | Acetylation | TSGPVITKLIFAKPI CCCCCEEEEEEEEEC | 28.58 | 19608861 | |
| 249 | Acetylation | ITKLIFAKPINSKAV EEEEEEEEECCCCCC | 35.36 | 19608861 | |
| 249 | Ubiquitination | ITKLIFAKPINSKAV EEEEEEEEECCCCCC | 35.36 | 19608861 | |
| 253 | O-linked_Glycosylation | IFAKPINSKAVTGQT EEEEECCCCCCCCCC | 23.78 | 20068230 | |
| 254 | Ubiquitination | FAKPINSKAVTGQTT EEEECCCCCCCCCCC | 42.25 | - | |
| 257 | Phosphorylation | PINSKAVTGQTTQVS ECCCCCCCCCCCCCC | 28.56 | 24732914 | |
| 260 | Phosphorylation | SKAVTGQTTQVSPPV CCCCCCCCCCCCCCE | 22.12 | 24732914 | |
| 261 | Phosphorylation | KAVTGQTTQVSPPVI CCCCCCCCCCCCCEE | 21.05 | 30266825 | |
| 264 | Phosphorylation | TGQTTQVSPPVIAGR CCCCCCCCCCEEECE | 17.42 | 23401153 | |
| 268 | Acetylation | TQVSPPVIAGRVLSQ CCCCCCEEECEEECC | 4.08 | 19608861 | |
| 268 | Ubiquitination | TQVSPPVIAGRVLSQ CCCCCCEEECEEECC | 4.08 | 19608861 | |
| 274 | Phosphorylation | VIAGRVLSQSTPGTP EEECEEECCCCCCCC | 21.16 | 30266825 | |
| 276 | Phosphorylation | AGRVLSQSTPGTPSK ECEEECCCCCCCCCC | 32.94 | 30266825 | |
| 276 | O-linked_Glycosylation | AGRVLSQSTPGTPSK ECEEECCCCCCCCCC | 32.94 | 20068230 | |
| 277 | Phosphorylation | GRVLSQSTPGTPSKT CEEECCCCCCCCCCE | 20.35 | 30266825 | |
| 280 | Phosphorylation | LSQSTPGTPSKTITI ECCCCCCCCCCEEEE | 26.12 | 30266825 | |
| 282 | Phosphorylation | QSTPGTPSKTITISE CCCCCCCCCEEEEEC | 42.12 | 30266825 | |
| 282 | O-linked_Glycosylation | QSTPGTPSKTITISE CCCCCCCCCEEEEEC | 42.12 | 20068230 | |
| 283 | Acetylation | STPGTPSKTITISES CCCCCCCCEEEEECC | 45.19 | 26051181 | |
| 288 | O-linked_Glycosylation | PSKTITISESGVIGS CCCEEEEECCCCCCC | 19.63 | 20068230 | |
| 290 | O-linked_Glycosylation | KTITISESGVIGSTL CEEEEECCCCCCCCC | 31.41 | 20068230 | |
| 295 | Phosphorylation | SESGVIGSTLNSTTQ ECCCCCCCCCCCCCC | 20.71 | 27080861 | |
| 296 | O-linked_Glycosylation | ESGVIGSTLNSTTQT CCCCCCCCCCCCCCC | 25.42 | 20068230 | |
| 296 | Phosphorylation | ESGVIGSTLNSTTQT CCCCCCCCCCCCCCC | 25.42 | 27080861 | |
| 299 | Phosphorylation | VIGSTLNSTTQTPNK CCCCCCCCCCCCCCE | 35.62 | 27251275 | |
| 300 | Phosphorylation | IGSTLNSTTQTPNKI CCCCCCCCCCCCCEE | 23.11 | 27080861 | |
| 301 | Phosphorylation | GSTLNSTTQTPNKIA CCCCCCCCCCCCEEE | 30.21 | 27080861 | |
| 303 | Phosphorylation | TLNSTTQTPNKIAIS CCCCCCCCCCEEEEC | 27.08 | 27080861 | |
| 310 | Phosphorylation | TPNKIAISPLKSPNK CCCEEEECCCCCCCH | 18.37 | 29255136 | |
| 313 | Ubiquitination | KIAISPLKSPNKAVK EEEECCCCCCCHHHH | 68.22 | - | |
| 314 | Phosphorylation | IAISPLKSPNKAVKS EEECCCCCCCHHHHC | 41.19 | 29255136 | |
| 321 | O-linked_Glycosylation | SPNKAVKSTVQTITV CCCHHHHCCCEEEEE | 27.49 | 20068230 | |
| 321 | Phosphorylation | SPNKAVKSTVQTITV CCCHHHHCCCEEEEE | 27.49 | 25332170 | |
| 332 | O-linked_Glycosylation | TITVGGVSTSQFKTI EEEECCCCHHHCEEE | 26.14 | 20068230 | |
| 333 | O-linked_Glycosylation | ITVGGVSTSQFKTII EEECCCCHHHCEEEE | 24.92 | 20068230 | |
| 333 | Phosphorylation | ITVGGVSTSQFKTII EEECCCCHHHCEEEE | 24.92 | 25332170 | |
| 344 | O-linked_Glycosylation | KTIIPLATAPNVQQI EEEEEECCCCCEEEE | 50.78 | 20068230 | |
| 344 | Phosphorylation | KTIIPLATAPNVQQI EEEEEECCCCCEEEE | 50.78 | 25332170 | |
| 357 | Acetylation | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 19608861 | |
| 357 | Ubiquitination | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 19608861 | |
| 357 | Sumoylation | QIQVPGSKFHYVRLV EEECCCCCEEEEEEE | 41.92 | 28112733 | |
| 371 | Phosphorylation | VTATSASSSTQPVSQ EEEECCCCCCCCCCC | 36.80 | - | |
| 397 | Phosphorylation | AKPVVVNTTPVRMSV CCCEEEECCCCCCCC | 22.37 | 27732954 | |
| 398 | Phosphorylation | KPVVVNTTPVRMSVP CCEEEECCCCCCCCC | 18.00 | 25159151 | |
| 413 | Ubiquitination | IVSAQAVKQVVPKPI EEEHHHHHCCCCCCC | 40.15 | - | |
| 418 | Ubiquitination | AVKQVVPKPINPTSQ HHHCCCCCCCCCCCC | 47.09 | - | |
| 418 | Acetylation | AVKQVVPKPINPTSQ HHHCCCCCCCCCCCC | 47.09 | 26051181 | |
| 429 | O-linked_Glycosylation | PTSQIVTTSQPQQRL CCCCEEECCCCCCEE | 17.92 | 20068230 | |
| 430 | O-linked_Glycosylation | TSQIVTTSQPQQRLI CCCEEECCCCCCEEE | 30.42 | 20068230 | |
| 430 | Phosphorylation | TSQIVTTSQPQQRLI CCCEEECCCCCCEEE | 30.42 | 26714015 | |
| 435 | Methylation | TTSQPQQRLIMPATP ECCCCCCEEECCCCC | 22.42 | - | |
| 515 | Phosphorylation | PFNGIIPSESASRPR CCCCCCCCCCCCCCC | 33.50 | 28555341 | |
| 529 | Ubiquitination | RKPCNCTKSLCLKLY CCCCCCCHHHHHHHH | 43.56 | - | |
| 569 | Ubiquitination | NERQKAIKACLDRNP HHHHHHHHHHHHCCH | 37.60 | - | |
| 580 | Ubiquitination | DRNPEAFKPKIGKGK HCCHHHHCCCCCCCC | 53.07 | - | |
| 580 | Acetylation | DRNPEAFKPKIGKGK HCCHHHHCCCCCCCC | 53.07 | 26051181 | |
| 582 | Ubiquitination | NPEAFKPKIGKGKEG CHHHHCCCCCCCCCC | 65.76 | - | |
| 608 | Ubiquitination | CKRSGCLKNYCECYE CCCCCCCHHHHHHHH | 50.36 | - | |
| 635 | Phosphorylation | GCKNFEESPERKTLM CCCCCCCCCCHHHHH | 25.51 | 23401153 | |
| 639 | Sumoylation | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | - | |
| 639 | Sumoylation | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | 28112733 | |
| 639 | Ubiquitination | FEESPERKTLMHLAD CCCCCCHHHHHHHHH | 44.33 | - | |
| 640 | Phosphorylation | EESPERKTLMHLADA CCCCCHHHHHHHHHH | 35.22 | 24719451 | |
| 659 | Sumoylation | VQQQTAAKTKLSSQI HHHHHHHHHHHHHHH | 43.67 | 28112733 | |
| 661 | Sumoylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | - | |
| 661 | Sumoylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | 28112733 | |
| 661 | Ubiquitination | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | - | |
| 661 | Acetylation | QQTAAKTKLSSQISD HHHHHHHHHHHHHHH | 45.74 | 25953088 | |
| 663 | Phosphorylation | TAAKTKLSSQISDLL HHHHHHHHHHHHHHH | 23.04 | 26714015 | |
| 664 | Phosphorylation | AAKTKLSSQISDLLT HHHHHHHHHHHHHHH | 41.80 | 26714015 | |
| 667 | Phosphorylation | TKLSSQISDLLTRPT HHHHHHHHHHHHCCC | 17.99 | 28555341 | |
| 671 | Phosphorylation | SQISDLLTRPTPALN HHHHHHHHCCCCCCC | 41.73 | 26714015 | |
| 683 | Ubiquitination | ALNSGGGKLPFTFVT CCCCCCCCCCEEEEC | 57.15 | - | |
| 683 | Acetylation | ALNSGGGKLPFTFVT CCCCCCCCCCEEEEC | 57.15 | 26051181 | |
| 710 | Ubiquitination | AQAEQADKKGKSKAA HHHHHHCCCCCCHHH | 67.45 | - | |
| 711 | Ubiquitination | QAEQADKKGKSKAAA HHHHHCCCCCCHHHH | 72.60 | - | |
| 715 | Acetylation | ADKKGKSKAAAERMI HCCCCCCHHHHHHHH | 45.60 | 7365103 | |
| 741 | Sumoylation | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - | |
| 741 | Sumoylation | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - | |
| 741 | Ubiquitination | INSAGKAKSDPCAMN HHHCCCCCCCCCCCC | 59.90 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LIN54_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LIN54_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LIN54_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LIN9_HUMAN | LIN9 | physical | 17531812 | |
| LIN37_HUMAN | LIN37 | physical | 17531812 | |
| LIN52_HUMAN | LIN52 | physical | 17531812 | |
| MYBB_HUMAN | MYBL2 | physical | 17531812 | |
| E2F4_HUMAN | E2F4 | physical | 17531812 | |
| RBL2_HUMAN | RBL2 | physical | 17531812 | |
| TFDP1_HUMAN | TFDP1 | physical | 17531812 | |
| TFDP2_HUMAN | TFDP2 | physical | 17531812 | |
| RBBP4_HUMAN | RBBP4 | physical | 17531812 | |
| MYBA_HUMAN | MYBL1 | physical | 17531812 | |
| LIN9_HUMAN | LIN9 | physical | 17671431 | |
| LIN37_HUMAN | LIN37 | physical | 17671431 | |
| MYBB_HUMAN | MYBL2 | physical | 17671431 | |
| RBBP4_HUMAN | RBBP4 | physical | 17671431 | |
| RBL2_HUMAN | RBL2 | physical | 17671431 | |
| RBL1_HUMAN | RBL1 | physical | 17671431 | |
| E2F4_HUMAN | E2F4 | physical | 17671431 | |
| RBL2_HUMAN | RBL2 | physical | 19725879 | |
| MYBB_HUMAN | MYBL2 | physical | 19725879 | |
| MYBB_HUMAN | MYBL2 | physical | 25368258 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-244; LYS-249 AND LYS-357,AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310 AND SER-314, ANDMASS SPECTROMETRY. | |